Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process

Area of Science:

• Neuroimmunology
• Multiple Sclerosis Pathogenesis
• Axonal Regeneration

Background:

• Relapsing-remitting multiple sclerosis (MS) treatments have focused on neuroinflammation, primarily targeting Th1 and Th17 cells.
• Emerging evidence highlights the role of B cells in MS immunopathogenesis, leading to the development of B cell-targeted therapies.
• B-cell activating factor (BAFF) is crucial for B cell survival and differentiation, acting through multiple signaling pathways.

Purpose of the Study:

• To review current evidence on BAFF-dependent signaling through the Nogo receptor (NgR) complex.
• To elucidate the association between BAFF and NgR within the central nervous system (CNS).
• To highlight the potential of targeting the BAFF-NgR pathway as a therapeutic strategy for MS.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of signaling pathways involving BAFF and NgR.
• Examination of the role of these molecules in CNS injury and disease models.

Main Results:

• BAFF positively regulates B cell survival and differentiation.
• The Nogo receptor (NgR) and its homologs inhibit axonal regeneration in the CNS.
• Evidence suggests BAFF may signal through the NgR multimeric complex within the CNS.

Conclusions:

• The BAFF-NgR interaction represents a potential pathogenic mechanism in MS.
• Targeting this molecular complex could offer novel therapeutic strategies to reduce MS relapse rates and disease progression.
• Further research into BAFF-NgR signaling is warranted for developing advanced MS treatments.